These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 39011266)

  • 1. Association Between NAD(P)H Quinone Oxidoreductase 1 (NQO1) Gene Methylation/Expression and Bleeding Incidence Among an Iranian Population Undergoing Warfarin Therapy.
    Hosseini MS; Pourgholi L; Ziaee S; Pourgholi M; Mandegary A; Boroumand M
    Indian J Hematol Blood Transfus; 2024 Jul; 40(3):517-521. PubMed ID: 39011266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation of a non-CpG island promoter represses NQO1 expression in rat arsenic-transformed lung epithelial cells.
    Huang N; Pei X; Lin W; Chiu JF; Tao T; Li G
    Acta Biochim Biophys Sin (Shanghai); 2018 Aug; 50(8):733-739. PubMed ID: 29889218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of NAD(P)H quinone oxidoreductase 1 polymorphisms on stable warfarin doses in Korean patients with mechanical cardiac valves.
    Chung JE; Chang BC; Lee KE; Kim JH; Gwak HS
    Eur J Clin Pharmacol; 2015 Oct; 71(10):1229-36. PubMed ID: 26257249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic silencing of NAD(P)H:quinone oxidoreductase 1 by hepatitis B virus X protein increases mitochondrial injury and cellular susceptibility to oxidative stress in hepatoma cells.
    Wu YL; Wang D; Peng XE; Chen YL; Zheng DL; Chen WN; Lin X
    Free Radic Biol Med; 2013 Dec; 65():632-644. PubMed ID: 23920313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypermethylation of NAD(P)H: quinone oxidoreductase 1 (NQO1) gene in human hepatocellular carcinoma.
    Tada M; Yokosuka O; Fukai K; Chiba T; Imazeki F; Tokuhisa T; Saisho H
    J Hepatol; 2005 Apr; 42(4):511-9. PubMed ID: 15763338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NAD(P)H: quinone oxidoreductase 1 and NRH:quinone oxidoreductase 2 polymorphisms in papillary thyroid microcarcinoma: correlation with phenotype.
    Lee J; Kim KS; Lee MH; Kim YS; Lee MH; Lee SE; Kim YK; Ryu MJ; Kim SJ; Choi MJ; Jo YS
    Yonsei Med J; 2013 Sep; 54(5):1158-67. PubMed ID: 23918565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The NAD(P)H:quinone oxidoreductase locus in human colon carcinoma HCT 116 cells resistant to mitomycin C.
    Hu LT; Stamberg J; Pan S
    Cancer Res; 1996 Nov; 56(22):5253-9. PubMed ID: 8912865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of VKORC1, CYP4F2 and NQO1 gene variants on warfarin dose requirement in Han Chinese patients with catheter ablation for atrial fibrillation.
    Li J; Yang W; Xie Z; Yu K; Chen Y; Cui K
    BMC Cardiovasc Disord; 2018 May; 18(1):96. PubMed ID: 29776386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism.
    Jamieson D; Wilson K; Pridgeon S; Margetts JP; Edmondson RJ; Leung HY; Knox R; Boddy AV
    Clin Cancer Res; 2007 Mar; 13(5):1584-90. PubMed ID: 17332305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism with esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population.
    Zhang J; Schulz WA; Li Y; Wang R; Zotz R; Wen D; Siegel D; Ross D; Gabbert HE; Sarbia M
    Carcinogenesis; 2003 May; 24(5):905-9. PubMed ID: 12771035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the contribution of NAD(P)H-dependent quinone oxidoreductase 1 (NQO1) to the reduction of vitamin K in wild-type and NQO1-deficient mice.
    Ingram BO; Turbyfill JL; Bledsoe PJ; Jaiswal AK; Stafford DW
    Biochem J; 2013 Nov; 456(1):47-54. PubMed ID: 24015818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleotide and deduced amino acid sequence of a human cDNA (NQO2) corresponding to a second member of the NAD(P)H:quinone oxidoreductase gene family. Extensive polymorphism at the NQO2 gene locus on chromosome 6.
    Jaiswal AK; Burnett P; Adesnik M; McBride OW
    Biochemistry; 1990 Feb; 29(7):1899-906. PubMed ID: 1691923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung cancer in Mexican-Americans and African-Americans is associated with the wild-type genotype of the NAD(P)H: quinone oxidoreductase polymorphism.
    Wiencke JK; Spitz MR; McMillan A; Kelsey KT
    Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):87-92. PubMed ID: 9037558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction and Scavenging of Chemically Reactive Drug Metabolites by NAD(P)H:Quinone Oxidoreductase 1 and NRH:Quinone Oxidoreductase 2 and Variability in Hepatic Concentrations.
    den Braver-Sewradj SP; den Braver MW; Toorneman RM; van Leeuwen S; Zhang Y; Dekker SJ; Vermeulen NPE; Commandeur JNM; Vos JC
    Chem Res Toxicol; 2018 Feb; 31(2):116-126. PubMed ID: 29281794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of NQO1 levels and its genetic polymorphism with susceptibility to methamphetamine dependence.
    Liu H; Zhang W; Deng XD; Ma Y; Liu Y
    Mol Genet Genomic Med; 2021 Oct; 9(10):e1789. PubMed ID: 34467676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NAD(P)H:quinone oxidoreductase-1 overexpression predicts poor prognosis in small cell lung cancer.
    Cui X; Jin T; Wang X; Jin G; Li Z; Lin L
    Oncol Rep; 2014 Dec; 32(6):2589-95. PubMed ID: 25231218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NAD(P)H:quinone oxidoreductase 1 Arg139Trp and Pro187Ser polymorphisms imbalance estrogen metabolism towards DNA adduct formation in human mammary epithelial cells.
    Singh S; Zahid M; Saeed M; Gaikwad NW; Meza JL; Cavalieri EL; Rogan EG; Chakravarti D
    J Steroid Biochem Mol Biol; 2009 Oct; 117(1-3):56-66. PubMed ID: 19628038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NAD(P)H: quinone oxidoreductase 1 attenuates oxidative stress and apoptosis by regulating Sirt1 in diabetic nephropathy.
    Qiu D; Song S; Wang Y; Bian Y; Wu M; Wu H; Shi Y; Duan H
    J Transl Med; 2022 Jan; 20(1):44. PubMed ID: 35090502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NAD(P)H-dependent quinone oxidoreductase 1 (NQO1) and cytochrome P450 oxidoreductase (CYP450OR) differentially regulate menadione-mediated alterations in redox status, survival and metabolism in pancreatic β-cells.
    Gray JP; Karandrea S; Burgos DZ; Jaiswal AA; Heart EA
    Toxicol Lett; 2016 Nov; 262():1-11. PubMed ID: 27558805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association analysis of NAD(P)H:quinone oxidoreductase gene 609 C/T polymorphism with Alzheimer's disease.
    Wang B; Jin F; Xie Y; Tang Y; Kan R; Zheng C; Yang Z; Wang L
    Neurosci Lett; 2006 Dec; 409(3):179-81. PubMed ID: 17027152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.